Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial.

MLA

Darvishi-Khezri, Hadi, et al. “Iron-Chelating Effect of Silymarin in Patients with β-Thalassemia Major: A Crossover Randomised Control Trial.” Phytotherapy Research : PTR, vol. 32, no. 3, Mar. 2018, pp. 496–503. EBSCOhost, https://doi.org/10.1002/ptr.5995.

APA

Darvishi-Khezri, H., Salehifar, E., Kosaryan, M., Karami, H., Mahdavi, M., Alipour, A., & Aliasgharian, A. (2018). Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial. Phytotherapy Research : PTR, 32(3), 496–503. https://doi.org/10.1002/ptr.5995

Chicago

Darvishi-Khezri, Hadi, Ebrahim Salehifar, Mehrnoush Kosaryan, Hossein Karami, Mohammadreza Mahdavi, Abbas Alipour, and Aily Aliasgharian. 2018. “Iron-Chelating Effect of Silymarin in Patients with β-Thalassemia Major: A Crossover Randomised Control Trial.” Phytotherapy Research : PTR 32 (3): 496–503. doi:10.1002/ptr.5995.